Advertisement Clarient partners with JVHL to offer cancer assays - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Clarient partners with JVHL to offer cancer assays

Clarient, a provider of anatomic pathology and molecular testing services, has signed a one-year agreement with Joint Venture Hospital Laboratories to provide a wide-range of cancer testing to its 120 hospital-affiliated labs.

JVHL is located in Allen Park, Michigan and the agreement is renewable after the first year.

Paul Valenstein, president of Joint Venture Hospital Laboratories (JVHL), said: “This partnership provides more testing options for the pathologists and hospitals in the JVHL network. We are encouraged by this new relationship with Clarient and are pleased to provide our doctors with the benefit of Clarient’s cancer assays.”